Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|
Theseus Pharmaceuticals, Inc. last posted its earnings results on Thursday, March 14th, 2024. The company reported $-0.35 earnings per share for the quarter, missing analysts' consensus estimates of $-0.33 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Theseus Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.22 diluted earnings per share) and currently has a price-to-earnings ratio of -6.29. Theseus Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 8th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/17/2023 | Q3 2023 | -$0.35 | -$0.31 | 0.04 | $0 | $0 |
08/10/2023 | Q2 2023 | -$0.34 | -$0.34 | 0 | $0 | $0 |
05/11/2023 | Q1 2023 | -$0.42 | -$0.29 | 0.13 | $0 | |
03/09/2023 | Q4 2022 | -$0.44 | -$0.40 | 0.04 | $0 | |
11/03/2022 | Q3 2022 | -$0.34 | -$0.35 | -0.01 | $0 | |
08/11/2022 | Q2 2022 | -$0.29 | -$0.29 | 0 | $0 | |
05/12/2022 | Q1 2022 | -$0.25 | -$0.27 | -0.02 | $0 | |
03/10/2022 | Q4 2021 | -$0.23 | -$0.24 | -0.01 | $0 | |
11/15/2021 | Q3 2021 | -$0.24 | -$0.21 | 0.03 | $0 | |
06/30/2021 | Q2 2021 | -$0.19 | $0 | |||
03/31/2021 | Q1 2021 | -$0.18 | $0 | |||
12/31/2020 | Q4 2020 | -$0.11 | $0 | |||
09/29/2020 | Q3 2020 | -$0.06 | $0 |
Theseus Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 8th, 2024 based off last year's report dates.
The conference call for Theseus Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Theseus Pharmaceuticals, Inc.'s latest earnings report can be read online.
Theseus Pharmaceuticals, Inc. (:THRX) has a recorded net income of $0. Theseus Pharmaceuticals, Inc. has generated $-1.22 earnings per share over the last four quarters.
Theseus Pharmaceuticals, Inc. (:THRX) has a price-to-earnings ratio of -6.29 and price/earnings-to-growth ratio is -2.17.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED